FDA limits J&J COVID-19 vaccine due to rare blood clot risk!

The Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare risk of blood clots.

Source: FDA limits J&J COVID-19 vaccine due to rare blood clot risk – ABC News